Absci and AMD Announce Collaboration and Strategic

VANCOUVER, Washington, January 8, 2025 (GLOBE NEWSWIRE) — Absci Company (NASDAQ: ABSI), a data-driven generative AI drug creation company, today announced a strategic collaboration with AMD to deploy AMD Instinct™ accelerators and ROCm™ software to power critical AI drug discovery workloads, including advanced Absci capabilities new Antibody design models. AMD will also invest $20 million…

Read More

Strategic entry into undervalued and high growth assets

While the cryptocurrency market sails in macroeconomic uncertainty and regulatory clarity at the end of 2025, investors are increasingly turning to altcoins with robust fundamentals and a technical dynamic. Bitcoin domination oscillating around 58 to 60% and Altcoin capitalization showing signs of rotation, the next growth phase depends on projects that combine deflationary mechanics, institutional…

Read More